(Reuters) – The coronavirus variant first identified in Brazil, known as P.1, is resistant to three of the four antibody therapies with emergency use authorization in the United States, according to a laboratory study. Researchers exposed the P.1 variant to various monoclonal antibodies, including the four currently being used to treat U.S. COVID-19 patients – […]
A big change in drug treatment for cancer is arriving in Georgia. It’s not a new medication. What’s coming is something known as “white bagging,” an insurer tactic involving expensive infusion or injection drugs. And at Crisp Regional Health Services in Cordele, Jennifer Taylor, an oncology nurse practitioner, is concerned about the ultimate effect on patient […]
This is the third in a series of articles on delivering cancer treatment at home. If providing cancer therapies at home means handing off patients to a home-infusion company, Tennessee Oncology wants no part of it. The Nashville-based practice, one of the largest community-based practices in the country, is built on a business model that […]
Rituximab, an anti-cancer drug targeting the membrane protein CD20, was the first approved therapeutic antibody against B tumor cells. Immunologists at the University of Freiburg have now solved a mystery about how it works. A team headed by Professor Dr. Michael Reth used cell cultures, healthy cells, and cells from cancer patients to investigate how […]
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. MABTHERA IV NHL AND CLL 160310 For the treatment of Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukaemia pronounced (mab-thir-ra) contains the active ingredient rituximab (rch) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about MabThera intravenous infusion.It […]
